A-867191

Fluoroquinolone
Abbott Laboratories, USA
1994
  • Highest development stage: Phase 2

  • Development dropped

  • Gram-positive activity

  • Gram-negative activity

  • Mechanism of Action/Target pathogen: Broad spectrum antibiotic which demonstrated potent activity against E. coli, K. pneumoniae, L. monocytogenes, S. viridans, C. freundii to name a few

  • Source: https://adis.springer.com/drugs/800004047